Largest pharmaceuticals by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 pharmaceuticals ranked by total debt, at ZAR 1.16T, ahead of Pfizer (ZAR 1.11T) and Merck & Co (ZAR 848B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieZAR 1.16T
- Median
- ZAR 90.7B
- Combined market value
- ZAR 88.5T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | ZAR 1.16T | ZAR 8.87T | ZAR 5,016.18 | 0.42% down | 26% up | ||
| 2 | PfizerPFE · Health Care | ZAR 1.11T | ZAR 2.79T | ZAR 489.61 | 0.02% up | 14% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 848B | ZAR 5.96T | ZAR 2,418.56 | 1.95% down | 51% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | ZAR 824.6B | ZAR 11.53T | ZAR 4,788.28 | 0.16% down | 38% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | ZAR 775.9B | ZAR 2.14T | ZAR 1,048.03 | 0.73% down | 34% up | ||
| 6 | Eli LillyLLY · Health Care | ZAR 731.1B | ZAR 21.71T | ZAR 24,370.01 | 0.10% up | 35% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | ZAR 525.9B | ZAR 1.18T | ZAR 370.24 | 0.55% down | 54% up | ||
| 8 | AstraZenecaAZN · Health Care | ZAR 509.5B | ZAR 4.83T | ZAR 3,111.14 | 0.74% down | 2% up | ||
| 9 | NovartisNVS · Health Care | ZAR 494.2B | ZAR 5.12T | ZAR 2,710.11 | 1.01% down | 25% up | ||
| 10 | SanofiSNY · Health Care | ZAR 356.9B | ZAR 1.96T | ZAR 817.88 | 0.04% up | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | ZAR 334.3B | ZAR 3.06T | ZAR 694.13 | 0.86% down | 17% down | ||
| 12 | GSKGSK · Health Care | ZAR 330B | ZAR 1.7T | ZAR 846.61 | 0.01% down | 6% up | ||
| 13 | ViatrisVTRS · Health Care | ZAR 247.9B | ZAR 406.1B | ZAR 354.24 | 0.71% up | 96% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | ZAR 222.4B | ZAR 3.12T | ZAR 1,800.98 | 0.05% down | 17% down | ||
| 15 | ZoetisZTS · Health Care | ZAR 155.5B | ZAR 587.6B | ZAR 1,446.05 | 0.71% up | 29% down | ||
| 16 | Royalty PharmaRPRX · Health Care | ZAR 154B | ZAR 680.8B | ZAR 1,184.08 | 0.23% up | 78% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 92.2B | ZAR 265.3B | ZAR 4,133.02 | 0.18% down | 37% up | ||
| 18 | GenmabGMAB · Health Care | ZAR 90.7B | ZAR 550.8B | ZAR 893.22 | 0.06% down | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | ZAR 69.1B | ZAR 227.1B | ZAR 454.27 | 2.17% up | 20% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 44.2B | ZAR 128.3B | ZAR 368.21 | 1.36% up | 83% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | ZAR 34.5B | ZAR 258.1B | ZAR 1,324.78 | 0.29% up | 17% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 34.2B | ZAR 1.72T | ZAR 16,596.25 | 0.74% up | 36% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | ZAR 31.2B | ZAR 78.8B | ZAR 473.01 | 2.00% up | 64% down | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 17.7B | ZAR 804.9B | ZAR 7,046.36 | 0.87% down | 17% up | ||
| 25 | Ascendis PharmaASND · Health Care | ZAR 13.7B | ZAR 305.8B | ZAR 4,662.02 | 0.06% down | 28% up | ||
| 26 | InsmedINSM · Health Care | ZAR 9.4B | ZAR 460.7B | ZAR 2,099.84 | 0.18% up | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 5.8B | ZAR 168B | ZAR 7,232.47 | 0.36% down | 24% down | ||
| 28 | Legend BiotechLEGN · Health Care | ZAR 5.5B | ZAR 56B | ZAR 288.80 | 4.22% up | 42% down | ||
| 29 | CytokineticsCYTK · Health Care | ZAR 4.9B | ZAR 124.7B | ZAR 895.37 | 0.78% up | 20% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | ZAR 4.2B | ZAR 165B | ZAR 1,091.78 | 1.22% up | 107% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | ZAR 3.8B | ZAR 84.7B | ZAR 486.60 | 1.58% up | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 3.3B | ZAR 214.2B | ZAR 256.98 | 0.95% up | 5% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | ZAR 3.2B | ZAR 123.6B | ZAR 2,349.93 | 0.49% up | 7% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 1.9B | ZAR 138.2B | ZAR 1,993.71 | 0.60% down | 13% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | ZAR 698M | ZAR 69.4B | ZAR 506.90 | 0.31% up | 169% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2005 ZAR). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by total debt?
AbbVie (ZAR 1.16T), Pfizer (ZAR 1.11T) and Merck & Co (ZAR 848B) are the top three of the 35 pharmaceuticals ranked by total debt as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 35 pharmaceuticals ranked by total debt have a combined market value of ZAR 88.5T as of 18 Nov 2026, 14:39 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.